Fundz

Tango Therapeutics Raises $60 Million Series B Financing and Strengthens Executive Team

PUBLIC · TNGXApr 09, 2020

Amount Raised

$60 Million

Round Type

Series B

BostonHealthcareHealth Care

Description

Tango Therapeutics, a biotechnology company focused on discovering and delivering the next generation of targeted cancer therapies, today announced the closing of an oversubscribed Series B financing of $60 million led by Boxer Capital of the Tavistock Group. Cormorant Asset Management and Casdin Capital are additional new investors in the round.

Quick answer

Tango Therapeutics raised $60 Million in a Series B round, dated April 9, 2020. Tango Therapeutics is based in Boston, Massachusetts, United States.

How much did Tango Therapeutics raise?
Tango Therapeutics raised $60 Million in a Series B round on April 9, 2020.
What does Tango Therapeutics do?
Tango Therapeutics is a clinical-stage biotechnology company pioneering the next generation of precision cancer medicines.
Where is Tango Therapeutics based and how big is it?
Tango Therapeutics is based in Boston, Massachusetts, United States. Fundz records about 169 employees.
Who are the decision-makers at Tango Therapeutics?
Fundz holds 3 contacts at Tango Therapeutics, including the Senior Information Technology Manager. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Health Care around the same time

Companies in the same sectors as Tango Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Axial Therapeutics raised $7.8M on May 22, 2020.
  • Novabay raised $1K on May 22, 2020.
  • Check-Cap Ltd raised $3M (Seed) on May 21, 2020.
  • AseptiScope, Inc. raised $4.2M (Seed) on May 20, 2020.
  • Amwell raised $134M on May 20, 2020.
  • EnsoData raised $9M on May 19, 2020.

Who to call at Tango Therapeutics, and when

A new round usually means Tango Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Tango Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Tango Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Tango Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Tango Therapeutics

Location

201 BROOKLINE AVENUE

Boston, Massachusetts, United States

About

Tango Therapeutics is a clinical-stage biotechnology company pioneering the next generation of precision cancer medicines. Founded in 2017 with a $55 million Series A investment from Third Rock Ventures, the company leverages advances in DNA sequencing and CRISPR-based target discovery to develop breakthrough therapies with deeper, more durable benefits than current treatments. Focused on three key areas—loss of tumor suppressor gene function, multiple oncogenic drivers, and immune evasion—Tango uses synthetic lethality to selectively target cancer cells while sparing healthy tissue. By combining deep genetic insights with cutting-edge science, Tango aims to accelerate the development of transformational therapies for patients with cancers lacking effective treatment options.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Tango Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsBen-Oni J., Senior Information Technology ManagerSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Tango Therapeutics's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Tango Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.